India link in fresh US insider trading scam
Top Stories
- UPA II report card: Govt flaunts stricter rape law, remains silent on graft
- CSK team principal: Avid golfer, fast car lover, married to cricket
- British soldier hacked to death in suspected Islamist attack
- Top Lashkar militant Hilal Molvi killed in Kashmir encounter
- Sanjay Dutt's life at Yerwada begins as prisoner number 16656
A prominent Indian-origin hedge fund portfolio manager has been charged with participating in one of the "most lucrative" insider trading schemes ever in the US.
Mathew Martoma, 38, has been charged with using material, non-public information that he received from a doctor on the clinical trial of an Alzheimer's drug to make profits and avoid losses for his hedge fund for an amount totalling approximately $276 million.
Martoma, who was arrested last week from his home in Boca Raton, Florida, was released on Monday on a $5 million bail after a brief hearing at the Manhattan federal court here. He did not enter any plea and the judge set the next hearing for December 26.
The US Securities and Exchange Commission has also filed a civil insider trading case against him.
BCCI has its way, Siva beats May in dodgy re-vote for ICC post
Politics to ministry work, Bansal picks family first
In deal to end standoff with China, India agreed to give up key bunker
Rail bribery row: CBI finds links that could lead up to minister BansalEditors’ Pick
- Paddy shortfall blamed for mystery death of procurement officer
- 'Bookie' Vindoo was close to BCCI chief's son-in-law: cops
- Spot-fixing probe widens, Delhi top cop says 3 more players are under scanner
- British soldier hacked to death in suspected Islamist attack
- Malegaon 2006 case: NIA names four right wing terror suspects
- BJP invokes 'sarcasm, ridicule' against PM
- Nine years on, Sonia, PM put up show of unity, Singh hints at unfinished business
